轻度认知障碍患者的自杀倾向:一个主题性综述
Alba Sánchez-Gil1, Jesús Pérez2,3,4,5,6, Víctor Navarro-López7
1National Centre of Reference for People with Alzheimer's Disease and other Dementias, Salamanca, 37008, Spain.
BMC psychiatry
|August 12, 2025
概括
轻度认知障碍 (MCI) 患者面临更高的自杀思想和行为 (STB) 风险. 综合护理模式对于预防这一群体的自杀至关重要.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 精神病学是一个精神病学.
背景情况:
- 轻度认知障碍 (MCI) 是正常衰老和痴呆之间的过渡阶段.
- 肌痛性脑损伤与功能衰退,社会隔离和情绪困扰有关,可能会增加自杀风险.
- 了解MCI和自杀思想和行为 (STB) 之间的联系对于有针对性的干预至关重要.
研究的目的:
- 研究轻度认知障碍 (MCI) 与自杀思想和行为 (STB) 之间的关系.
- 为了确定临床和社会经济因素,有助于MCI个体的STB.
主要方法:
- 对科学文献进行了全面的系统审查.
- 在主要数据库 (PubMed,Scopus,Cochrane Library,WOS,EMBASE) 进行了搜索,截至2024年6月.
- 通过纽卡斯尔-太华尺度和ROBINS-E.评估研究质量.
主要成果:
- 11项研究符合最初1176个出版物的资格标准.
- 与对照人群相比,被诊断出MCI的个体表现出更高的性传播疾病患病率.
- 伴随性疾病 (抑郁症,心血管疾病),低社会经济地位和低教育程度与MCI中自杀风险增加有关.
结论:
- 系统性审查表明,患有MCI的个体中STB的风险增加.
- 建议综合卫生和社会护理模型用于针对MCI的老年人自杀预防计划.
相关概念视频
Depressive Disorders: Etiology
169
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
169
Negative and Cognitive Symptoms of Schizophrenia
123
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
123
Depressive Disorders: MDD and Dysthymia
214
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
214
Antidepressant Drugs: MAOIs and Other Agents
349
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
349
Psychological and Sociocultural Causes of Schizophrenia
187
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
187
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206


